C07D 295/12
Substituted by singly or doubly bound nitrogen atoms
Official title: substituted by singly or doubly bound nitrogen atoms (nitro radicals C07D295/06)
C07D295/12 (Substituted by singly or doubly bound nitrogen atoms) appears on 2,535 US grants and 2,107 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,535
- Published applications
- 2,107
- Assignees
- 1,144
- Inventors
- 7,146
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 48 | 0 |
| 1977 | 46 | 0 |
| 1978 | 40 | 0 |
| 1979 | 42 | 0 |
| 1980 | 39 | 0 |
| 1981 | 26 | 0 |
| 1982 | 25 | 0 |
| 1983 | 11 | 0 |
| 1984 | 33 | 0 |
| 1985 | 23 | 0 |
| 1986 | 30 | 0 |
| 1987 | 32 | 0 |
| 1988 | 33 | 0 |
| 1989 | 30 | 0 |
| 1990 | 38 | 0 |
| 1991 | 49 | 0 |
| 1992 | 37 | 0 |
| 1993 | 44 | 0 |
| 1994 | 41 | 0 |
| 1995 | 61 | 0 |
| 1996 | 44 | 0 |
| 1997 | 65 | 0 |
| 1998 | 48 | 0 |
| 1999 | 52 | 0 |
| 2000 | 53 | 0 |
| 2001 | 51 | 15 |
| 2002 | 80 | 97 |
| 2003 | 73 | 146 |
| 2004 | 83 | 144 |
| 2005 | 65 | 118 |
| 2006 | 81 | 93 |
| 2007 | 68 | 84 |
| 2008 | 65 | 93 |
| 2009 | 55 | 101 |
| 2010 | 63 | 106 |
| 2011 | 50 | 59 |
| 2012 | 74 | 73 |
| 2013 | 72 | 79 |
| 2014 | 68 | 100 |
| 2015 | 64 | 79 |
| 2016 | 70 | 69 |
| 2017 | 78 | 70 |
| 2018 | 38 | 45 |
| 2019 | 61 | 64 |
| 2020 | 42 | 73 |
| 2021 | 47 | 67 |
| 2022 | 53 | 69 |
| 2023 | 38 | 71 |
| 2024 | 39 | 63 |
| 2025 | 39 | 74 |
| 2026 | 28 | 55 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Ionizable cationic lipid analog material and use thereof as drug delivery carrier29 Sep 2026US 12,746,288 B2Guangzhou Lide Biomedicine Technology Co., Ltd.
- GluN2B-subunit selective antagonists of the N-methyl-D-aspartate receptors with enhanced potency at acidic pH29 Sep 2026US 12,747,221 B2Emory Univeristy
- Lipoxygenase inhibitors22 Sep 2026US 12,741,926 B2SRI International
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Small molecule BAX inhibitors and uses thereof18 Aug 2026US 12,708,621 B2Albert Einstein College of Medicine
- Disperse dyes for dyeing polyester fibres8 Oct 2026US 2026/0308841 A1University of Leeds
- Pyridine-piperazine-based scaffolds as highly potent and selective neurolysin activators1 Oct 2026US 2026/0294897 A1Board of Regents of the University of Nebraska
- Lipid nanoparticle for targeted delivery of therapeutic payloads24 Sep 2026US 2026/0285801 A1Trustees of Tufts College
- Salts and crystalline forms of lm11a31 and methods of use thereof10 Sep 2026US 2026/0263476 A1PharmatrophiX, Inc.
- Aromatic compounds for use as protein phosphatase 2a (pp2a) modulators10 Sep 2026US 2026/0265190 A1Rappta Therapeutics Oy
Most cited
By later US patents
- Lipids and compositions for intracellular delivery of biologically active compounds247US 8,691,750 B2Axolabs GmbH · 2014
- Drug composition containing nucleic acid copolymer208US 5,705,188 ANippon Shinyaku Co., Ltd. · 1998
- Aminoalcohol lipidoids and uses thereof207US 8,450,298 B2Massachusetts Institute of Technology · 2013
- Amphipathic PH sensitive compounds and delivery systems for delivering biologically active compounds149US 5,965,434 A1999
- Ligands for metals and improved metal-catalyzed processes based thereon143US 6,307,087 B1Massachusetts Institute of Technology · 2001